Beyond Air posts record quarterly revenue, awaits FDA decision on next-gen LungFit PHNov 13Quarterly updateBeyond Air, Inc
Aclaris reports Q3 2026 results, positive ATI-052 data, and 2029 cash runwayNov 5Quarterly updateAclaris Therapeutics, Inc.
Beyond Air preannounces $2.3 million revenue, reaffirms 2026 and 2027 guidanceOct 9Quarterly updateBeyond Air, IncRetension Pharmaceuticals, IncUpdated
Novlead registers post-market study of INOwill N200 nitric oxide device for neonatal PPHNSep 24Trial updatenitric oxide